January 6, 2017 · STOCK Act disclosure
Representative James R. Langevin (Democrat-RI) sold Alexion Pharmaceuticals, Inc., a stock transaction, valued at $15,001 - $50,000. The trade took place on January 6, 2017 and was disclosed on January 13, 2017 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.